| 9.17 0 (0%) | 04-17 16:00 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |   |
|||
| Targets | 6-month : | 12.38 | 1-year : | 14.43 |
| Resists | First : | 10.6 | Second : | 12.35 |
| Pivot price | 9.01  |
|||
| Supports | First : | 7.76 | Second : | 6.46 |
| MAs | MA(5) : | 8.91 |
MA(20) : | 9.65 |
| MA(100) : | 13.98 |
MA(250) : | 20.91 |
|
| MACD | MACD : | -0.8 |
Signal : | -0.9 |
| %K %D | K(14,3) : | 34.5 |
D(3) : | 29 |
| RSI | RSI(14): 41.4 | |||
| 52-week | High : | 32.75 | Low : | 7.76 |
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.[ PHR ] has closed below upper band by 45.8%. Bollinger Bands are 3.3% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 9.51 - 9.55 | 9.55 - 9.59 |
| Low: | 9.02 - 9.08 | 9.08 - 9.12 |
| Close: | 9.08 - 9.17 | 9.17 - 9.24 |
Phreesia, Inc. provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. Its Phreesia Platform offers a suite of solutions to manage the patient intake process, as well as an integrated payments solution for processing of patient payments. The company deploys its platform in a range of modalities, such as Phreesia Mobile, a patients' mobile device; Phreesia Dashboard, a web-based dashboard for healthcare services clients; PhreesiaPads, which are self-service intake tablets; and Arrivals Kiosks that are on-site kiosks. Its Phreesia Platform also provides a registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, and cost estimation tools; access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking; and life sciences solution to deliver targeted and clinically relevant marketing content to patients. In addition, the company's Phreesia Platform offers clinical support solution, which collects clinical intake and patient reported outcome (PRO) data for approximately 25 specialties, as well as enables healthcare services clients to communicate with their patients through surveys, announcements, text and email messaging, and health campaigns; and COVID-19 support modules for managing COVID-19 vaccine delivery and identify vaccine-hesitant patients, screening for self-reported COVID-19 risk factors, enabling contactless check-in during in-person visits, and collecting intake information during telehealth visits. It serves patients; single-specialty practices, multi-specialty groups, and health systems; and pharmaceutical, medical device, and biotechnology companies. The company was incorporated in 2005 and is headquartered in Raleigh, North Carolina.
Fri, 17 Apr 2026
Wells Fargo maintains overweight rating on Phreesia (PHR) - MSN
Fri, 17 Apr 2026
Rosen Law Firm Encourages Phreesia, Inc. Investors to Inquire About Securities Class Action Investigation – PHR - Business Wire
Fri, 17 Apr 2026
Yvonne Hui Sells 10,063 Shares of Phreesia (NYSE:PHR) Stock - MarketBeat
Fri, 17 Apr 2026
Phreesia (PHR) accounting officer sells 10,063 shares under 10b5-1 plan - Stock Titan
Fri, 17 Apr 2026
PHR (NYSE: PHR) Form 144 shows 10,063-share sale; 1,327 shares vesting - Stock Titan
Thu, 16 Apr 2026
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Phreesia, Inc. - PHR - PR Newswire
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Outperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NYSE
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Healthcare Information Services
|
|
| Shares Out | 60 (M) |
| Shares Float | 52 (M) |
| Held by Insiders | 4.8 (%) |
| Held by Institutions | 113.1 (%) |
| Shares Short | 4,400 (K) |
| Shares Short P.Month | 3,460 (K) |
| EPS | -0.1 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 5.32 |
| Profit Margin | -1.2 % |
| Operating Margin | -46.7 % |
| Return on Assets (ttm) | -0.3 % |
| Return on Equity (ttm) | -1.9 % |
| Qtrly Rev. Growth | 45.7 % |
| Gross Profit (p.s.) | 5.23 |
| Sales Per Share | 7.68 |
| EBITDA (p.s.) | 0.23 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 61 (M) |
| Levered Free Cash Flow | 33 (M) |
| PE Ratio | -101.89 |
| PEG Ratio | 0 |
| Price to Book value | 1.72 |
| Price to Sales | 1.19 |
| Price to Cash Flow | 9 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|